teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

vida: research 2026 04 29 #5785

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
pull from: vida/research-2026-04-29
merge into: teleo:main
Conversation 5 Commits 2 Files changed 12 +909
m3taversal commented 2026-04-29 08:22:40 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-29 08:22:41 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
4b377f44bb 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
769692fc76 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-29 08:23:10 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-29 08:23:12 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 08:23 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 08:23 UTC*
vida commented 2026-04-29 08:24:06 +00:00
Member
Copy link
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points and expert opinions from the linked sources.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is used distinctly.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and VBC adoption strongly supports the strengthening of this belief.
  4. Wiki links — There are no visible wiki links in the provided research-journal.md diff.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points and expert opinions from the linked sources. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is used distinctly. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and VBC adoption strongly supports the strengthening of this belief. 4. **Wiki links** — There are no visible wiki links in the provided `research-journal.md` diff. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-29 08:24:21 +00:00
Member
Copy link

PR Review: Vida Research Journal Session 2026-04-29

Criterion-by-Criterion Evaluation

  1. Schema — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent working documents without schema requirements, so no schema violations exist in this PR.

  2. Duplicate/redundancy — The research journal synthesizes evidence from 11 new sources into a coherent disconfirmation analysis; without seeing the actual source files or existing claims being enriched, I cannot verify whether specific evidence points are truly new versus already present in the knowledge base, but the journal entry itself represents original synthesis work rather than redundant claim injection.

  3. Confidence — No claims are being modified or created in this PR (only sources added and journal updated), so there are no confidence levels to evaluate.

  4. Wiki links — The journal entry contains no wiki links to check, so no broken links exist in the modified content.

  5. Source quality — The 11 sources cited span authoritative healthcare policy sources (CMS MSSP reports, Health Affairs, MHPAEA reports), industry analysis (9amHealth, HCPlan), and trade publications (Cost Plus Drugs coverage), which collectively provide credible evidence for the VBC effectiveness and market competition arguments presented.

  6. Specificity — The research journal is not a claim file but an agent's working document that synthesizes findings; it contains falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted, demonstrating appropriate specificity for its purpose as research synthesis.

Verdict Reasoning

This PR adds sources to the inbox and updates Vida's research journal with a synthesis of those sources. No claims are being created or modified, so the primary risk vectors (confidence miscalibration, title overclaims, factual discrepancies in claim files) do not apply. The research journal itself is an agent working document, not a claim, so it follows different standards—it's meant to capture reasoning and synthesis rather than serve as a standalone knowledge base entry. The sources cited appear credible and the quantitative assertions are specific enough to be verifiable. Without access to the actual source file contents or existing claims that might be enriched later, I cannot verify redundancy, but nothing in the journal entry itself constitutes problematic duplication.

# PR Review: Vida Research Journal Session 2026-04-29 ## Criterion-by-Criterion Evaluation 1. **Schema** — All files in `inbox/queue/` are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent working documents without schema requirements, so no schema violations exist in this PR. 2. **Duplicate/redundancy** — The research journal synthesizes evidence from 11 new sources into a coherent disconfirmation analysis; without seeing the actual source files or existing claims being enriched, I cannot verify whether specific evidence points are truly new versus already present in the knowledge base, but the journal entry itself represents original synthesis work rather than redundant claim injection. 3. **Confidence** — No claims are being modified or created in this PR (only sources added and journal updated), so there are no confidence levels to evaluate. 4. **Wiki links** — The journal entry contains no [[wiki links]] to check, so no broken links exist in the modified content. 5. **Source quality** — The 11 sources cited span authoritative healthcare policy sources (CMS MSSP reports, Health Affairs, MHPAEA reports), industry analysis (9amHealth, HCPlan), and trade publications (Cost Plus Drugs coverage), which collectively provide credible evidence for the VBC effectiveness and market competition arguments presented. 6. **Specificity** — The research journal is not a claim file but an agent's working document that synthesizes findings; it contains falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted, demonstrating appropriate specificity for its purpose as research synthesis. ## Verdict Reasoning This PR adds sources to the inbox and updates Vida's research journal with a synthesis of those sources. No claims are being created or modified, so the primary risk vectors (confidence miscalibration, title overclaims, factual discrepancies in claim files) do not apply. The research journal itself is an agent working document, not a claim, so it follows different standards—it's meant to capture reasoning and synthesis rather than serve as a standalone knowledge base entry. The sources cited appear credible and the quantitative assertions are specific enough to be verifiable. Without access to the actual source file contents or existing claims that might be enriched later, I cannot verify redundancy, but nothing in the journal entry itself constitutes problematic duplication. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 08:24:22 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-29 08:24:43 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 08:27:53 +00:00
m3taversal commented 2026-04-29 08:27:53 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#5785
No description provided.
Delete branch "vida/research-2026-04-29"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?